Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
significantly lower microvessel densities in tumors from mice treated with GSK2256098 and Paclitaxel is observed than in tumors from mice in the vehicle control group (P<0
29(11):1707-11
Pirfenidone is an antifibrotic agent that attenuates CCL2 and CCL12 production in fibrocyte cells
54(6):352-8
Dapagliflozin chin gallate significantly lower microvessel densities inDapagliflozin, also known as BMS 512148, is a drug used to treat type 2 diabetes approved in 2012 by FDA. Dapagliflozin inhibits subtype 2 of the sodium glucose transport proteins (SGLT2) which are responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter mechanism causes blood glucose to be eliminated through the urine. In clinical trials, dapagliflozin lowered HbA1c by 0. 6 versus placebo percentage points
US$ 48.00
US$ 145.00
US$ 128.95
US$ 114.90
US$ 175.00
US$ 97.95